News for MCK Stock

McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions McKesson Corporation Declares Quarterly Dividend McKesson Corporation Completes Acquisition of PRISM Vision Holdings, LLC McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance McKesson Advances Specialty Leadership; Signs Agreement to Acquire Controlling Interest in PRISM Vision Holdings, LLC McKesson Corporation Declares Quarterly Dividend McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance McKesson Corporation Declares Quarterly Dividend McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release Date McKesson Corporation Announces Sale of Rexall and Well.ca Businesses to Birch Hill Equity Partners McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures McKesson Corporation Reports Fiscal 2025 First Quarter Results McKesson Raises Quarterly Dividend by 15% to $0.71 Per Share McKesson Corporation Announces First Quarter Fiscal 2025 Earnings Release Date McKesson’s Board of Directors Elects Deborah Dunsire as New Director McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results McKesson Corporation Declares Quarterly Dividend McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance McKesson Corporation Declares Quarterly Dividend McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance McKesson Corporation Declares Quarterly Dividend KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth McKesson Corporation Reports Fiscal 2024 First Quarter Results McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date McKesson Corporation Announces the Expiration and Results of Tender Offer for Any and All 3.796% Notes Due 2024 McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024 McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024 McKesson Corporation Reports Fiscal 2023 Fourth-Quarter and Full-Year Results and Raises Long-Term Segment Growth Targets McKesson Corporation Declares Quarterly Dividend McKesson Corporation Announces Fourth-quarter Fiscal 2023 Earnings Release Date McKesson Medical-Surgical Government Solutions Awarded Federal Supply Schedule Medical Equipment and Supply Contract McKesson Corporation Reports Fiscal 2023 Third-Quarter Results McKesson Corporation Declares Quarterly Dividend McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance McKesson Corporation Declares Quarterly Dividend McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health McKesson Signs Agreement to Acquire Rx Savings Solutions McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer McKesson Corporation Reports Fiscal 2023 First-Quarter Results McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research McKesson Reports Fiscal 2022 Fourth-Quarter Results Distributors Agree to Opioid Settlement With Washington State McKesson Declares Quarterly Dividend McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date McKesson’s Board of Directors Elects W. Roy Dunbar as New Director Distributors Approve Opioid Settlement Agreement McKesson Reports Fiscal 2022 Third-Quarter Results McKesson Declares Quarterly Dividend McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference Distributors Announce Extension of Opioid Settlement Sign-On Period, Participation of New Mexico McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets McKesson to Host Investor Day on December 8, 2021 Walgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Joint Venture From McKesson McKesson Reports Fiscal 2022 Second-Quarter Results McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS McKesson Declares Quarterly Dividend Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors Distributors Announce Settlement With Cherokee Nation McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021 Mckesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase McKesson to Host Investor Day on December 8, 2021 McKesson Reports Fiscal 2022 First-Quarter Results McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share McKesson Corporation Announces Pricing and Upsizing of Tender Offer McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap Distributors Announce Proposed Opioid Settlement Agreement Distributors Reach Opioid Settlement Agreement With New York State McKesson Corporation Announces Offer to Purchase up to $500 Million Aggregate Principal Amount of Debt McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021 McKesson Reports Fiscal 2021 Fourth-Quarter and Full-Year Results McKesson Declares Quarterly Dividend McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021 McKesson Reports Fiscal 2021 Third-Quarter Results McKesson Declares Quarterly Dividend McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences McKesson Appoints Dr. Kelvin A. Baggett to Chief Impact Officer McKesson’s Board of Directors Elects Linda Mantia as New Independent Director McKesson Corporation to Announce Second Quarter Fiscal 2021 Results on November 3, 2020